The neural crest is a transient structure in vertebrate embryos. Neural crest cells arise within the neural tube, migrate ventrally and laterally, and contribute significantly to a wide variety of cell types, including melanocytes, peripheral neurons and their glial cells, smooth muscle cells, and skeletal derivatives (Le Douarin and Kalcheim, 1999; Hall, 1999) . Cranial neural crest cells migrate beneath the ectoderm and populate cranial ganglia of the peripheral nervous system (PNS) to differentiate into glia and neurons. In contrast with the mechanisms of neurogenesis, those of glial differentiation in the PNS remain largely unknown.
Introduction
The neural crest is a transient structure in vertebrate embryos. Neural crest cells arise within the neural tube, migrate ventrally and laterally, and contribute significantly to a wide variety of cell types, including melanocytes, peripheral neurons and their glial cells, smooth muscle cells, and skeletal derivatives (Le Douarin and Kalcheim, 1999; Hall, 1999) . Cranial neural crest cells migrate beneath the ectoderm and populate cranial ganglia of the peripheral nervous system (PNS) to differentiate into glia and neurons. In contrast with the mechanisms of neurogenesis, those of glial differentiation in the PNS remain largely unknown.
Notch activation and fibroblast growth factor (FGF) 2 treatment promote the gliogenesis of mouse trunk neural crest cells (Morrison et al., 2000; Ota and Ito, 2006) . Since trunk neural crest cells differ from cranial neural crest cells in how they respond to specific extracellular signals (Abzhanov et al., 2003) , we analyzed the roles of Notch signaling and FGFs in the gliogenesis of mouse mesencephalic neural crest cells. We demonstrated Notch signaling is an evolutionarily conserved mechanism that influences various biological processes, such as cell fate specification, differentiation, proliferation, and apoptosis (Artavanis-Tsakonas et al., 1999; Miele and Osborne, 1999) . Notch signaling is known to have different Notch receptor downstream pathways: RBP-J-dependent and Deltex-dependent pathways (Kato et al., 1997; Matsuno et al., 1995; Yamamoto et al., 2001) . Both types of pathways regulate various cellular behaviors independently or interactively (Kato et al., 1997; Yamamoto et al., 2001; Patten et al., 2006) . We have shown that Notch signaling activated by FGFs promotes the chondrogenic specification of mouse mesencephalic neural crest cells (Nakanishi et al., 2007) . Therefore, we focused on the differences in the downstream Notch receptor pathways between gliogenesis and chondrogenesis. The present data show that the activation of the Deltex-mediated pathway by means of FGFs promotes the gliogenesis of mesencephalic neural crest cells and that chondrogenesis requires the activation of both RBP-J-dependent and Deltex-dependent pathways.
Results

Effects of Notch signaling and FGFs on the differentiation of glia
When mouse mesencephalic neural crest cells were cultured in the presence of a fusion protein containing the extracellular domain of a Notch ligand, Delta-1, and the Fc region of human immunoglobulin IgG (Delta-Fc) or FGFs, a large number of small and stellate cells appeared within 24 h in culture. In the absence of Delta-Fc and FGFs or in the cultures containing the Fc region of human immunoglobulin IgG (Fc) only, on the other hand, many flattened cells were found. To examine the effects of Notch signaling and FGFs on the gliogenesis of mesencephalic neural crest cells, we detected glia by means of immunocytochemistry using anti-glial fibrillary acidic protein (GFAP) antibodies and counted the number of cells containing GFAP on culture day 4. The percentage of cells expressing GFAP per neural crest cell colony (each colony was derived from a primary explant) dramatically increased in the presence of Delta-Fc and FGF2 (Fig. 1A-D) . Treatment with FGF4 or FGF8 also promoted GFAP expression, but the effect of each was weaker than that of FGF2 (Fig. 1D) . Anti-GFAP-positive cells displayed a small and dendritic morphology and were first observed after 2 days in culture.
We examined the effects of Delta-Fc and FGF2 on the proliferation of the neural crest cells using the 5-bromo-2 0 -deoxyuridine (BrdU) incorporation method. Whereas the percentage of BrdU-incorporated cells significantly increased by FGF2 treatment at 4 days in culture (Fig. 1H) , neither Delta-Fc nor FGF2 had any effects on the proliferation of GFAPexpressing cells as shown by double-labeling experiments using anti-GFAP and anti-BrdU (Fig. 1E -G and I).
Critical Notch-sensitive period for gliogenesis
To establish whether or not there is a critical period during which Notch signaling is required for gliogenesis, mouse mesencephalic neural crest cells were exposed to Delta-Fc during several distinct periods of the cultures. Exposure to Delta-Fc during the period 0-24 h or the period 24-48 h in culture promoted GFAP expression ( Fig. 2A) . Delta-Fc treatment for the first 48 h was the most critical for the stimulation of GFAP expression ( Fig. 2A) . However, exposure during the period 48-72 h or the period 72-96 h did not promote GFAP expression ( Fig. 2A) . Furthermore, the overexpression of the mouse Notch-1 intracellular domain (Notch-IC) by transfection with the expression vector encoding Notch-IC during the first 48 h stimulated GFAP expression ( Fig. 2A) . The most critical exposure period of FGF2 for GFAP expression was also the first 48 h in culture (Fig. 2B ). These observations show that the critical exposure period of Delta-Fc or FGF2 for GFAP expression differs from that for chondrogenesis, which was the first 24 h in culture (Nakanishi et al., 2007) .
The first 48 h in culture were both Notch-sensitive and FGF2-sensitive periods for GFAP expression. Therefore, we analyzed the functional relationship between FGF2 and Notch signaling using Notch-1 siRNA to block Notch-1 expression. The effect of Notch-1 siRNA was examined by immunostaining with anti-Notch-1. Anti-Notch-1-positive cells were observed in the absence of siRNA (Fig. 2D ) or in the presence of a negative control of Notch-1 siRNA (Fig. 2E) . Cells immunoreactive to anti-Notch-1 were hardly observed when Notch-1 siRNA was transfected (Fig. 2F) . Thus, Notch-1 expression was effectively prevented by Notch-1 siRNA (Nakanishi et al., 2007) . When mouse mesencephalic neural crest cell cultures were treated with Notch-1 siRNA during the first 48 h in the presence of FGF2, the percentage of GFAP-expressing cells significantly decreased (Fig. 2C ). This suppression of GFAP expression by Notch-1 siRNA was recovered by treatment with Notch-IC expression vector (Fig. 2C) . Moreover, GFAP expression was prevented by the treatment with SU5402, which is an inhibitor of FGF signaling (Wang et al., 2006) , during the first 48 h despite the presence of FGF2 (Fig. 2C ). The treatment with Delta-Fc or Notch-IC expression vector recovered this prevention (Fig. 2C ).
2.3.
Expression patterns of Delta, Notch-1 and p75 in vivo
We investigated the expression patterns of Delta, Notch-1, and p75, which is a marker for undifferentiated neural crest cells (Rao and Anderson, 1997) , in the presumptive trigeminal ganglionic region of the mouse embryo, where mesencephalic neural crest cells colonize and undergo gliogenesis. At embryonic day (E) 8.5 (12-somite stage), intense immunoreactivities against anti-Delta, anti-Notch-1, and anti-p75 were observed throughout this region ( Fig. 3A-E) . Most of the anti-Delta-positive cells expressed Notch-1 (Fig. 3D) . The expression of Delta and Notch-1 was also observed at E9.5 (25-somite stage, Fig. 3F-J) . However, the expression of p75 slightly decreased from E8.5 to E9.5 (Fig. 3J) . The expression levels of Delta, Notch-1, and p75 declined at E10.5 (39-somite stage, Fig. 3K-O) . Furthermore, we examined the expression patterns of p75 and Notch-1 in mouse mesencephalic neural crest cell cultures to confirm that these are co-expressed in the neural crest cells. When the expression of p75 and Notch-1 was analyzed on culture day 1, eighty percent (79.8(±3.7)%) of the cells immunoreactive against anti-Notch-1 expressed p75 (Fig. 3P-S) .
2.4.
Effects of RBP-J and Deltex on the differentiation of glia and chondrocytes Notch-IC interacts with DNA binding protein RBP-J to modulate gene transcription (Jarriault et al., 1995; Kato et al., 1997; Artavanis-Tsakonas et al., 1999) . Furthermore, it is also known that Deltex regulates Notch signaling through interactions with the Notch-IC (Matsuno et al., 1995; Yamamoto et al., 2001 ). To examine whether or not Notch signaling regulates the differentiation of mouse mesencephalic neural crest cells into glia or chondrocytes through either RBP-J or Deltex, the neural crest cells were transfected with the expression vector encoding RBP-J or Deltex-1 during the first 24 h or the first 48 h in culture. In the transfection of the control vector, the percentages of GFAP-and collagen type II (a marker for chondrocytes)-expressing cells per neural crest cell colony were 1.11 ± 0.09% and 3.00 ± 0.72%, respectively. When the RBP-J expression vector was transfected, the percentage of anticollagen type II-positive cells increased significantly, similar to the case in Notch-IC overexpression ( Fig. 4C and G) . However, the expression of GFAP was not promoted (Fig. 4E ). In the transfection of the Deltex-1 expression vector, on the other hand, the percentages of both collagen type II-and GFAP-positive cells increased (Fig. 4A, F and H) . The transfection of the expression vectors encoding dominant negative (dn) RBP-J or dn Deltex-1 had no effects on the expression of collagen type II and GFAP (Fig. 4B, . Furthermore, whereas the accelerated expression of both collagen type II and GFAP by Notch-IC overexpression or FGF2 treatment was efficiently down-regulated by dn Deltex-1 ( Fig. 4F and H), dn RBP-J suppressed collagen type II expression only ( Fig. 4E and G).
2.5.
Effects of Hairy enhancer of split (Hes) 1 and Hes5 on the differentiation of glia and chondrocytes Hes1 and Hes5 have been known as target genes of Notch signaling . To examine whether or not Hes1 and Hes5 participate in the differentiation of mouse mesencephalic neural crest cells into glia and chondrocytes, the neural crest cells were transfected with the expression vector encoding Hes1 or Hes5 during the first 24 h or the first 48 h in culture. The expression of collagen type II and GFAP was promoted by the transfection of the Hes1 expression vector, similar to the case with Notch-IC overexpression ( Fig. 5A and B) . Transfection of the Hes5 expression vector also stimulated collagen type II and GFAP expression ( Fig. 5A and B) . However, the effect of Hes5 on collagen type II expression was lower than that of Hes1 (Fig. 5A ).
RBP-J activates Hes1 and Hes5 (Iso et al., 2003; Zhu et al., 2007) , but the relation between Deltex and Hes is unknown. GFAP expression was promoted by Deltex-1, but not by RBP-J, and was also promoted by Hes1 and Hes5. Therefore, we analyzed whether or not Deltex can activate Hes. When the neural crest cells were transfected with the Deltex-1 expression vector, the percentage of anti-Hes1-positive cells per neural crest cell colony increased significantly, compared with the transfection of the dn Deltex-1 expression vector (Fig. 5C ). Furthermore, we carried out the transfection of the Deltex-1 expression vector together with the dn RBP-J expression vector to examine whether or not the induction of Hes1 by Deltex is dependent on RBP-J. Transfection of the dn RBP-J expression vector had no effects on the promotion of Hes1 expression by Deltex-1 (Fig. 5C ). More intense immunoreactivity against anti-Hes1 was also found in the transfection of the Deltex-1 expression vector ( Fig. 5D and E).
Effects of FGF2 on the lineage segregation of mouse mesencephalic neural crest cells
The present and previous (Nakanishi et al., 2007 ) data indicate that Notch signaling and FGFs are involved in the differentiation of both glia and chondrocytes, but the Notchsensitive and FGF-sensitive periods are different between gliogenesis and chondrogenesis. The downstream pathways of the Notch receptor in Notch signaling were also different. These results suggest that Notch signaling and FGFs affect different populations of mouse mesencephalic neural crest cells that exhibit differential competence: (1) developmentally restricted cells with gliogenic potential (DRGP) and (2) developmentally restricted cells with chondrogenic potential (DRCP). Thus, Notch signaling and FGFs may act not on the lineage segregation of DRGP and DRCP from pluripotent neural crest cells, but on the differentiation from DRGP or DRCP into glia or chondrocytes. To strengthen this hypothesis, we examined the effects of FGF2 on the lineage segregation of DRGP and DRCP from pluripotent neural crest cells. The cells were treated with FGF2 during the culture periods 0-24 h, 24- (Fig. 6A-C) . FGF2 did not affect the proportion of each clone type (Fig. 6D ).
Discussion
FGFs participate in the specification of glia by means of Notch activation
Notch activation and FGF2 treatment promote the gliogenesis of mouse trunk neural crest cells (Morrison et al., 2000; Ota and Ito, 2006) . The present data demonstrated that the activation of Notch signaling and FGF treatment stimulated GFAP expression of mouse mesencephalic neural crest cells. This result indicates that Notch signaling and FGFs positively regulate the differentiation of these cells into glia and play similar roles in the gliogenesis of trunk and cranial neural crest cells.
FGF2 treatment or Notch activation during the first 48-h period was sufficient to promote the differentiation of mesencephalic neural crest cells into glia. Furthermore, we have revealed that mesencephalic neural crest cells during this culture period are in an undifferentiated state in which they express p75 (Nakanishi et al., 2007) . Thus, Notch signaling and FGF2 may act at the early stages of the gliogenic differentiation of mesencephalic neural crest cells. It is conceivable that Notch signaling and FGFs may be responsible for the specification of glia. FGF2 has been shown to promote the expression of Notch-1 (Ota and Ito, 2006) . Moreover, the promotion of gliogenic differentiation by FGF2 was suppressed by Notch-1 siRNA treatment. Notch activation by Delta-Fc treatment or Notch-IC transfection sufficiently promoted gliogenic differentiation in the cultures treated with SU5402. These data suggest that FGFs activate Notch signaling and that this activation stimulates the specification of mouse mesencephalic neural crest cells to glia.
No significant differences were found with respect to the proportion of GFAP-expressing cells labeled with BrdU under any of the conditions examined. Therefore, it is conceivable that the increase in the number of GFAP-expressing cells is due to the promotion of gliogenic differentiation by Notch activation or FGF treatment. Furthermore, nuclear staining with 4 0 6-diamino-2-phenylindole (DAPI) revealed hardly any cell death in all culture conditions examined during the first 48 h, which is the critical culture period for the promotion of gliogenesis by Notch activation or FGF treatment. This observation suggests that the extent of cell survival and death during the first 48 h is unchanged among the present culture conditions. Thus, Notch activation and FGF treatment are not likely to promote the survival of glial precursors selectively. These results also support the notion that Notch activation and FGF treatment participate in the specification of mouse mesencephalic neural crest cells to glia. Notch activation by FGFs is known to promote the chondrogenic specification of mouse mesencephalic neural crest cells (Nakanishi et al., 2007) . In chondrogenic specification, however, the critical Notch-sensitive period was the first 24 h in culture. Thus, Notch signaling and FGFs may play important roles in both gliogenic and chondrogenic specification, but the time responsible for the specification may be different between glia and chondrocytes.
3.2.
Notch signaling promotes gliogenic specification in mouse trigeminal ganglia Mouse mesencephalic neural crest cells migrate ventrolaterally along a subectodermal pathway and populate the trigeminal ganglia (Chan and Tam, 1988; Osumi-Yamashita et al., 1994) . They undergo gliogenesis and neurogenesis in the trigeminal ganglia. Since the arrival of mouse cranial neural crest cells at the trigeminal ganglia is completed by E8.5-9.0 (Chan and Tam, 1988; Serbedzija et al., 1992) , the formation of these ganglia starts by E8.5-9.0. Our data show that mesencephalic neural crest cells have the capacity to undergo gliogenic specification during the first 48 h in culture. Therefore, the specification of mesencephalic neural crest cells to glia may occur after the colonization of the trigeminal ganglia. The expression of Notch-1, Delta and p75 was observed in the E8.5-9.5 presumptive trigeminal ganglia. Thus, in the mouse, glial specification mediated by FGFs and Notch signaling may occur in the presumptive trigeminal ganglia around E8.5-9.5. Furthermore, the expression level of p75 dramatically declined at E10.5. This result suggests that the neural crest cell-derived progenitors of the trigeminal ganglia initiate the differentiation by E10.5. The expression of Delta and Notch-1 also decreased at E10.5. These in vivo observations correspond with the in vitro data that the specification of mesencephalic neural crest cells to glia occurs during the first 48 h.
Specification of mouse mesencephalic neural crest cells to glia or chondrocytes requires the expression of Hes by RBP-J-dependent and/or Deltex-dependent pathways
In canonical Notch signaling, ligand binding induces receptor proteolysis to release the Notch-IC. Notch-IC translocates to the nucleus and forms a complex with RBP-J through the Notch-IC ankyrin repeat to convert RBP-J from transcriptional repressor to transcriptional activator (Jarriault et al., 1995; Kato et al., 1997; Artavanis-Tsakonas et al., 1999) . Deltex also positively regulates Notch signaling through the interactions with Notch-IC ankyrin repeats (Matsuno et al., 1995) , independent of the RBP-J-dependent pathway. The present data show that RBP-J promotes the specification of mouse mesencephalic neural crest cells to chondrocytes but not to glia. On the other hand, Deltex was involved in both chondrogenic and gliogenic specification. These results suggest that different Notch signaling pathways participate in the specification of glia and chondrocytes. 
The complex of Notch-IC and RBP-J activates the expression of Hes (Jarriault et al., 1995) . Hes1 and/or Hes5 inhibit neurogenesis and myogenesis (Sasai et al., 1992; Ishibashi et al., 1994; Ohtsuka et al., 1999) . In the present study, Hes1 and, to a lesser extent, Hes5 promoted chondrogenic specification. Hes1 and Hes5 also stimulated glial specification, although RBP-J was irrelevant to this specification. Furthermore, the overexpression of Deltex-1 promoted Hes1 expression, independent of RBP-J. These data suggest that Hes can be activated by both RBP-J-dependent and Deltex-dependent pathways in mouse mesencephalic neural crest cells. It is conceivable that Hes activation by both RBP-J-dependent and Deltex-dependent pathways affects the specification of chondrocytes, and that gliogenic specification is mediated by Hes activation by the Deltex-dependent pathway only.
Although both RBP-J-dependent and Deltex-dependent pathways play important roles in the specification of chondrocytes, the overexpression of either dn RBP-J or dn Deltex-1 suppressed the promotion of collagen type II expression by Notch activation. It is possible that Hes activation sufficient to promote chondrogenic specification may be achieved by activating both RBP-J-dependent and Deltex-dependent pathways. Thus, the prevention of the RBP-J-dependent or Deltex-dependent pathway by dn RBP-J or dn Deltex-1 may suppress Hes activation enough to promote the specification of chondrocytes. The gliogenic specification was promoted by the Deltex-dependent pathway only. During the glial differentiation, the RBP-J-mediated mechanism may repress glial fate and/or Deltex not only promotes gliogenesis but also may induce a factor that prevents chondrogenesis.
Notch signaling and FGFs affect the lineage segregation of developmentally restricted cells with gliogenic or chondrogenic potential
The neural crest is composed of a heterogeneous population of cells: pluripotent cells, cells with restricted developmental potentials and cells committed to a particular cell lineage (Baroffio et al., 1988; Bronner-Fraser and Fraser, 1989; Sieber-Blum, 1990; Fraser and Bronner-Fraser, 1991; Ito et al., 1993; Dupin et al., 1998) . We found three types of clones in the clonal cultures of mouse mesencephalic neural crest cells. It is conceivable that clones containing only GFAP-expressing cells are derived from developmentally restricted cells with gliogenic potential (DRGP), such as neuron/glia precursors (Le Douarin and Dupin, 2003; Ota and Ito, 2006) , and that clones with only anti-collagen type II-positive cells originate from developmentally restricted cells with chondrogenic potential (DRCP), such as ectomesenchymal cells that differentiate into chondrocytes, bones and connective tissue (Le Lièvre and Le Douarin, 1975; Le Douarin and Kalcheim, 1999) . Clones containing both GFAP-expressing cells and anti-collagen type II-positive cells may originate from pluripotent neural crest cells. Since Baroffio et al. (1991) have shown that quail cranial neural crest cells contain developmentally restricted cells with gliogenic and chondrogenic potentials, some clones with both GFAP-and collagen type II-expressing cells may be derived from them in mouse mesencephalic neural crest cells. FGF2 treatment did not affect the proportion of each clone type. This result suggests that Notch signaling and FGFs do not act on the lineage segregation of DRGP and DRCP from pluripotent neural crest cells or developmentally restricted cells with gliogenic and chondrogenic potentials. Thus, Notch signaling and FGFs may be essential in the specification of DRGP or DRCP to glia or chondrocytes (Fig. 6E ).
4.
Experimental procedures 4.1.
Mouse mesencephalic neural crest cell cultures
Primary cultures of mesencephalic neural crest cells were prepared from E8.0 (6-to 8-somite stages) ddY mouse embryos (Ito and Morita, 1995; Kubota and Ito, 2000; Ota and Ito, 2003; Nakanishi et al., 2007) . Neural folds at mesencephalic levels were dissected and cut into fragments. These fragments were explanted in 35-mm culture dishes coated with a collagen gel (PureCol). Epithelial components in the primary explants were scraped away with a tungsten needle after 48 h, leaving the emigrated mesencephalic neural crest cells on the substratum. Clonal cultures of mesencephalic neural crest cells were performed as described previously (Ito and Morita, 1995) . Neural crest cells were resuspended by trypsinization after removal of the epithelial components. This essentially single cell suspension (>90% single cells) was diluted with culture medium and 1 ml aliquots of this cell suspension were plated onto 35-mm culture dishes that were coated with a collagen gel and conditioned with culture medium containing 20 lg/ml plasma fibronectin (Itoham). The medium consisted of 85% a-modified minimum essential medium (a-MEM, Sigma), 10% fetal bovine serum (FBS, Hyclone), 5% extract of day 11 chick embryos, and 50 lg/ml gentamicin (Sigma). The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . The culture medium was changed every other day. FGF2, FGF4, and FGF8 (R&D Systems) were each added to the medium at a concentration of 10 ng/ml. SU5402 (Calbiochem) was used at 5 lM.
Treatment with Delta-Fc
The preparation of Delta-Fc and the Fc was described previously (Ota and Ito, 2006; Nakanishi et al., 2007) . Using the liposome method (TransIT-LT1, Takara), 0.8 lg of the pSMT expression vector encoding the extracellular domain of mouse Delta-1 and Fc (a gift from Dr. H. Hirai; Shimizu et al., 1999; Shimizu et al., 2000) or 2 lg of the vector encoding Fc only was transfected into COS7 cells. The transfected COS7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS. When the cultures became confluent, the medium was replaced with DMEM without FBS. After 5 days of incubation, the supernatant containing Delta-Fc or Fc was harvested from the cultures. The Delta-Fc-or Fcconditioned medium was concentrated by centrifugation in an Amicon Ultra-15 centrifugal filter device (Millipore) to achieve a 50-fold total net concentration. The concentrated supernatant was added to the neural crest cell cultures at a concentration of 40 ll per ml of culture medium (Morrison et al., 2000; Faux et al., 2001; Ota and Ito, 2006; Nakanishi et al., 2007) .
Transfection of the expression vectors
Mouse mesencephalic neural crest cells were transfected with 1-2 lg of the following expression vectors: (1) the pcDNA3 encoding the mouse Notch-IC and a myc epitope (a gift from Dr. J.S. Nye et al., 1994; Foltz et al., 2002) , (2) the pCMX-N/VP16 encoding the mouse RBP-J (a gift from Dr. T. Honjo; Kuroda et al., 1999; Tani et al., 2001) , (3) the pCMX-N/RBP-J (R218) encoding the dn mouse RBP-J (a gift from Dr. T. Honjo; Tani et al., 2001) , (4) the pCMV encoding the human Deltex-1 and a myc epitope (a gift from Dr. J.C. Aster; Izon et al., 2002) , (5) the pFLAG-CMV encoding the dn human Deltex-1 and a FLAG tag (a gift from Dr. J.C. Aster; Izon et al., 2002) , (6) the pCI encoding the mouse Hes 1 (a gift from Dr. R. Takebayashi et al., 1994; Ohtsuka et al., 2001) , and (7) the pCMV encoding the rat Hes5 (a gift from Dr. R. Kageyama; Ohtsuka et al., 2001) . The transfection was performed by using Lipofectamine 2000 (Invitrogen) for the first 24 h or the first 48 h in culture. The transfection efficiencies of the vectors encoding a myc epitope or a FLAG tag were estimated by immunostaining with mouse anti-c-myc (9E10) (1:100, Santa Cruz Biotechnology) or mouse anti-FLAG-M2 (1:20, Sigma). The efficiencies of the vectors without tags were estimated by co-transfection with the pFP-C1 encoding Green Fluorescent Protein (GFP) (Clontech) and immunostaining with rabbit anti-GFP (1:500, MBL). The percentage of cells expressing the myc epitope, FLAG tag, and GFP per neural crest cell colony reached 71.6(±3.3)%, 72.2(±2.8)%, and 74.9(±6.75)%, respectively. As a control experiment, pcDNA3 encoding the myc epitope only (control vector) was transfected.
siRNA preparation
The siRNA was prepared as described previously (Nakanishi et al., 2007) . The siRNA duplexes for Notch-1 were designed on the basis of Notch-1 sequences published online [GenBank Acces- 
4.5.
Immunostaining added to the cultures at a final concentration of 50 lM. The cultures were exposed to BrdU for 90 min and subsequently fixed in 4% PFA on ice for 1 h. BrdU-incorporated cells were detected with mouse monoclonal anti-BrdU antibodies (1:10, Becton-Dickinson). In double-stainings with anti-GFAP and anti-BrdU, FITCconjugated donkey anti-rabbit IgG and rhodamine-conjugated donkey anti-mouse IgG (1:50, Chemicon) were used as secondary antibodies. The cultures were nuclear-stained with 0.1 lg/ml DAPI for the total cell count.
